Articles Tagged With: anaphylaxis
-
Omalizumab Injection (Xolair)
The U.S. Food and Drug Administration has approved the first medication to help reduce allergic reactions, including anaphylaxis, that may occur after accidental exposure to multiple foods. Omalizumab is a recombinant humanized IgG1k monoclonal antibody that selectively binds to immunoglobulin E (IgE) lowering free serum IgE levels.
-
Managing Anaphylaxis in the Emergency Department
The incidence of anaphylaxis, a rapidly progressive and potentially fatal disease, is increasing and unfortunately common in children. It is imperative that all acute care providers are prepared to recognize, quickly treat, and ensure appropriate follow-up for these patients. The authors focus on anaphylaxis, its presentation, management, and disposition from the ED.
-
Ohio Court Revives Allergic Reaction Malpractice Suit
Before considering the statute of limitations aspects of this case, a healthcare professional should be cognizant of both the potential direct and indirect liability for failure to review and consider a patient’s medical history. Patient allergies are a crucial aspect of history-gathering since this may bring potentially life-threatening consequences.
-
CDC: Moderna COVID-19 Vaccine Causes Rare Anaphylactic Shock
From Dec. 21, 2020, to Jan. 10, 2021, the Vaccine Adverse Event Reporting System detected 10 cases of severe anaphylaxis after immunization with the Moderna COVID-19 vaccine, the Centers for Disease Control and Prevention reported. Ten cases coming out 4,041,396 first doses of the vaccine translates to 2.5 cases per million shots administered.
-
COVID-19 Shots Causing Anaphylactic Shock at 10 Times Rate of Other Vaccines
With millions more healthcare workers and the general public slated to be immunized for COVID-19, researchers report that the Pfizer SARS-CoV-2 mRNA vaccine is causing anaphylactic shock reactions at 10 times the rate of typical vaccines.
-
Rare, but Real: Anaphylaxis After COVID-19 Vaccination
As COVID-19 vaccinations roll out, a handful of people have experienced anaphylactic allergic reactions after receiving the Pfizer vaccine. These cases appear to be extremely rare, but the Centers for Disease Control and Prevention advises several measures to recognize and respond to severe allergic reactions to the vaccine.
-
Evaluation and Management of Anaphylaxis in the Emergency Department
For emergency physicians, anaphylaxis can be a challenging diagnosis to make. This article will present the most current information for diagnosing allergic reactions and anaphylaxis, and how to treat them properly.
-
Hypersensitivity Reactions in the Pediatric ED: The Tip of the Iceberg
Hypersensitivity reactions are very common. Understanding the different types, including serum sickness-like reactions, Stevens-Johnson syndrome, toxic epidermolytic necrolysis, and drug reaction with eosinophilia and systemic symptoms, is valuable both for an accurate and timely diagnosis as well as appropriate management.
-
Anaphylaxis: The Underrecognized Killer
This article will cover the presentation and emergency department (ED) management of allergic reactions in children, focusing on anaphylaxis. The current definition and recommended guidelines are reviewed.
-
Anaphylaxis: An Underrecognized Killer
Prompt diagnosis and treatment improve outcomes